Treatment of Hirsutism with a Gonadotropin-Releasing Hormone Agonist and Estrogen Replacement Therapy

    March 1994 in “ Fertility and sterility ”
    Roy N. Morcos, Michael E. Abdul-Malak, Evan Shikora
    TLDR The combination therapy reduced hirsutism in women with PCOD and was well-tolerated.
    The study aimed to evaluate the effectiveness of treating significant hirsutism in women with polycystic ovarian disease (PCOD) using a combination of a gonadotropin-releasing hormone agonist (GnRH-a) and estrogen and progestin replacement therapy. Conducted in an ambulatory gynecology clinic, the study involved 10 women who were treated with leuprolide acetate, estradiol, and medroxyprogesterone acetate for 6 months. Results showed a significant reduction in hirsutism scores and hair growth rates by 23% and 26%, respectively. The duration of hirsutism was the only significant covariate affecting these outcomes. The treatment was well-tolerated, with only two patients experiencing minimal, irregular bleeding, which was managed by adjusting the estrogen dose. The study concluded that this combination therapy was effective and well-tolerated for treating hirsutism in women with PCOD.
    Discuss this study in the Community →

    Research cited in this study

    2 / 2 results

    Related Community Posts Join

    6 / 24 results

      community AA and Hirsutism but T levels are normal

      in Female  8 upvotes 3 years ago
      27-year-old female experiences aggressive hair thinning and hirsutism despite normal testosterone levels. Spironolactone and 2% minoxidil were ineffective; high DHEA sulfate levels may be the cause.

      community No, Finasteride as a treatment for MPB was not an "accident"

      in Research/Science  105 upvotes 3 years ago
      Finasteride was intentionally developed to treat BPH and later approved for male pattern baldness (MPB) due to its 5AR inhibition effects. The delay in MPB approval was due to concerns about off-label use for female hirsutism and the prioritization of treating a more debilitating condition.

      community Coegin Pharma to release Follicopeptide (FOL005) by Q2 2025

      in Treatment  117 upvotes 2 months ago
      Follicopeptide (FOL005) by Coegin Pharma will launch as a cosmetic hair growth treatment by Q2 2025, showing similar efficacy to finasteride. Users discuss the benefits and skepticism of releasing hair loss treatments as cosmetics rather than drugs.

      community Does low HGH leading to hairloss?

      in Research/Science  13 upvotes 9 months ago
      The user experiencing diffuse hair loss is using various treatments including RU58841, finasteride, minoxidil with tretinoin, anti-hair loss shampoo, and microneedling, and is considering adding peptides TB500, BPC157, and GHK-Cu. They have low growth hormone levels and are questioning its impact on hair loss, while another user suggests androgenic alopecia and androgens are likely the main cause of hair loss.

      community Any balding females? I need advice with coping :(

       16 upvotes 8 years ago
      A 27-year-old woman is struggling with hair loss, feeling self-conscious and seeking advice on coping. She mentions trying Minoxidil but is hesitant due to scalp issues and is looking for ways to regain confidence.

    Related Research

    1 / 1 results